Advertisement

---

JANSSEN BIOTECH, INC.

Janssen And Johnson & Johnson Innovation Announce First-Of-Its-Kind Inflammatory Bowel Disease Research Alliance With The Icahn School Of Medicine At Mount Sinai

[2013-06-27] - -- Industry and Academic Teams Converge to Focus on the Discovery of Next Generation Therapeutic Solutions for the More Than Five Million People Affected by Inflammatory Bowel Disease Worldwide1 --


Five-Year SIMPONI Data Reported In Treatment Of Signs And Symptoms Of Moderately To Severely Active Rheumatoid Arthritis

[2013-06-12] - Data from Three Pivotal Phase 3 Trials Presented at 2013 EULAR Annual Congress


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers